Dr. Jennifer Lovejoy is a senior executive and biobehavioral scientist with deep experience in personalized medicine. During her academic career, Dr. Lovejoy held the Manship Endowed Professorship in Diabetes at LSU's Pennington Biomedical Research Center. She is a Past-President of the Obesity Society and has published over 80 peer-reviewed papers on her research. More recently, Dr. Lovejoy was Chief Translational Science Officer at Arivale, a precision medicine startup uniting systems biology and behavioral science to help consumers optimize wellness. Currently, she works at Seven.me, a digital health startup developing a unique behavioral AI platform combined with coaching and rapid at-home blood testing to help consumers transform their health.
I am a tenure-track Assistant Professor in the Department of Epidemiology at Johns Hopkins Bloomberg School of Public Health, a Core Faculty member in the Welch Center for Prevention, Epidemiology and Clinical Research. My research examines the nutritional, microbial, and environmental determinants of health across the lifespan, with the ultimate goal of identifying modifiable targets for chronic disease prevention and treatment. I believe that primary prevention of disease risk factors, in early life and among high-risk populations, provides the greatest opportunity to curb contemporary chronic disease epidemics and reduce health disparities. Accordingly, many of my investigations, in both local and global contexts, are in young, racially and ethnically diverse populations. A large part of my research focuses on the role of the human microbiome in nutrition and disease. I am particularly intrigued by the microbiome because it is amenable to intervention.
Sharpening Nutrition Science with the Microbiome
In this talk I will provide an overview of how the intestinal microbiota and their metabolites can inform more precise approaches to prevention and treatment of nutrition-related cardiometabolic diseases, including obesity, type 2 diabetes and obesity in both children and adults.
Maureen O’Connor is a senior healthcare executive passionate about driving change in our health care system to improve lives. Currently, she served as CEO of ZealCare, an early stage health care services and technology company, spun out of Duke, with a mission to empower people with complex chronic conditions to live the life they want. The company provides intensive, individualized support to participants and their care team through personalized planning, education and virtual group visits. Initially, Zeal is targeting individuals with chronic kidney disease and type 2 diabetes. Formerly, Maureen served as president of Whiterabbit.ai, a Silicon Valley company with a mission to eradicate late-stage breast cancer through the use of artificial intelligence. Maureen spent 17 years as an executive with Blue Cross Blue Shield of North Carolina, serving as EVP of diversified businesses, president of Mosaic Health Solutions, and chief strategy and innovation officer.
Sunjya K. Schweig, MD, is Founder and President of the California Center for Functional Medicine (CCFM). CCFM provides personalized, precision medicine care that is fundamental for managing patients with chronic illness. CCFM integrates a comprehensive care team with cutting edge technology and data. This high-touch and high-tech approach offers patients the optimal opportunity for prevention and recovery from complex chronic illness. As a global leader in the functional medicine movement, since 2016 CCFM has been honored to run comprehensive wellness programs for first responders to help mitigate the unique occupational risks that they experience. A graduate of the University of California, Berkeley, Dr. Schweig completed his MD at the University of California, Irvine, and his family medicine residency at the University of California, San Francisco (UCSF), Family Practice Residency Program in Santa Rosa, CA. He is board certified in family practice (ABFM) and integrative and holistic medicine (ABIHM).